These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 20222861)
1. Effect of administration route on the biodistribution and shedding of replication-deficient HAdV-5: a qualitative modelling approach. Tiesjema B; Hermsen HP; van Eijkeren JC; Brandon EF Curr Gene Ther; 2010 Apr; 10(2):107-27. PubMed ID: 20222861 [TBL] [Abstract][Full Text] [Related]
2. Effect of administration route on the biodistribution and shedding of replication-deficient AAV2: a qualitative modelling approach. Brandon EF; Hermsen HP; van Eijkeren JC; Tiesjema B Curr Gene Ther; 2010 Apr; 10(2):91-106. PubMed ID: 20222862 [TBL] [Abstract][Full Text] [Related]
3. An inventory of shedding data from clinical gene therapy trials. Schenk-Braat EA; van Mierlo MM; Wagemaker G; Bangma CH; Kaptein LC J Gene Med; 2007 Oct; 9(10):910-21. PubMed ID: 17880045 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse. Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942 [TBL] [Abstract][Full Text] [Related]
6. Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction. Johnson M; Huyn S; Burton J; Sato M; Wu L Hum Gene Ther; 2006 Dec; 17(12):1262-9. PubMed ID: 17117891 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous Administration of a Replication-Competent Adenovirus Expressing HSV-tk to Cotton Rats: Dissemination, Persistence, Shedding, and Pathogenicity. Wildner O; Morris JC Hum Gene Ther; 2002 Jan; 13(1):101-12. PubMed ID: 11779414 [TBL] [Abstract][Full Text] [Related]
8. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications. Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629 [TBL] [Abstract][Full Text] [Related]
9. Biodistribution and shedding of AAV vectors. Le Guiner C; Moullier P; Arruda VR Methods Mol Biol; 2011; 807():339-59. PubMed ID: 22034038 [TBL] [Abstract][Full Text] [Related]
10. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. Lemiale F; Kong WP; Akyürek LM; Ling X; Huang Y; Chakrabarti BK; Eckhaus M; Nabel GJ J Virol; 2003 Sep; 77(18):10078-87. PubMed ID: 12941918 [TBL] [Abstract][Full Text] [Related]
11. Development of an adenovirus-shedding assay for the detection of adenoviral vector-based vaccine and gene therapy products in clinical specimens. Wang F; Patel DK; Antonello JM; Washabaugh MW; Kaslow DC; Shiver JW; Chirmule N Hum Gene Ther; 2003 Jan; 14(1):25-36. PubMed ID: 12573056 [TBL] [Abstract][Full Text] [Related]
12. Prospects for gene therapy with direct injection of polynucleotides. Kass-Eisler A; Li K; Leinwand LA Ann N Y Acad Sci; 1995 Nov; 772():232-40. PubMed ID: 8546398 [No Abstract] [Full Text] [Related]
13. Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates. Kucharczuk JC; Raper S; Elshami AA; Amin KM; Sterman DH; Wheeldon EB; Wilson JM; Litzky LA; Kaiser LR; Albelda SM Hum Gene Ther; 1996 Dec; 7(18):2225-33. PubMed ID: 8953313 [TBL] [Abstract][Full Text] [Related]
14. Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters. Kim JW; Auffinger B; Spencer DA; Miska J; Chang AL; Kane JR; Young JS; Kanojia D; Qiao J; Mann JF; Zhang L; Wu M; Ahmed AU; Aboody KS; Strong TV; Hébert CD; Lesniak MS J Transl Med; 2016 May; 14(1):134. PubMed ID: 27184224 [TBL] [Abstract][Full Text] [Related]
16. An adenovirus type F41 outbreak in a pediatric bone marrow transplant unit: analysis of clinical impact and preventive strategies. Mattner F; Sykora KW; Meissner B; Heim A Pediatr Infect Dis J; 2008 May; 27(5):419-24. PubMed ID: 18382384 [TBL] [Abstract][Full Text] [Related]
18. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice. Dicks MD; Spencer AJ; Coughlan L; Bauza K; Gilbert SC; Hill AV; Cottingham MG Sci Rep; 2015 Nov; 5():16756. PubMed ID: 26576856 [TBL] [Abstract][Full Text] [Related]
19. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Wood M; Perrotte P; Onishi E; Harper ME; Dinney C; Pagliaro L; Wilson DR Cancer Gene Ther; 1999; 6(4):367-72. PubMed ID: 10419055 [TBL] [Abstract][Full Text] [Related]
20. Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues. Koski A; Bramante S; Kipar A; Oksanen M; Juhila J; Vassilev L; Joensuu T; Kanerva A; Hemminki A Mol Ther; 2015 Oct; 23(10):1641-52. PubMed ID: 26156245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]